Possible substantive improvements in the structure of the Quality of Life in Adult Cancer Survivors (QLACS) scale? A study based on its Spanish version

Vaíllo, Yolanda Andreu; Peiró, Andrea Conchado; López, Pedro Manuel Quesada; Martínez, María Teresa; Moreno, Pilar Conchello; Alpuente, L. Arribas

doi:10.1007/s11136-021-03036-4

Cited by 4 publications

(8 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The QLACS assesses health-related QOL in the past month on a seven-point Likert scale (1=never trough 7=always), with higher scores indicating lower HRQOL (except for positive feelings and benefits). Previous results with the Spanish version of QLACS support the good psychometric properties of the instrument as well as the obtaining of a total score on the scale, with the exclusion of the benefits-of-cancer domain (42) . Reliability indices obtained in this study were satisfactory (Cronbach's αTotal = .94; range Cronbach's αsubscales = .67 -.90).…”

Section: Methodsmentioning

confidence: 57%

Returning to work in cancer survivors: a multi-center cross-sectional study in Spain

et al. 2023

View full text Add to dashboard Cite

Objetivo: Analizar la situación laboral, así como variables sociodemográficas (edad, sexo, estado civil y titulación) relacionadas con el cáncer (tipo de cáncer, estrategia de tratamiento primario y fase de supervivencia) en supervivientes españoles de cáncer. Método y procedimiento: Estudio transversal sobre una muestra heterogénea de 772 supervivientes de cáncer de inicio en la edad adulta en edad laboral. Se realizaron análisis correlacionales y de regresión logística para estudiar la capacidad predictiva de las variables sociodemográficas y relacionadas con el cáncer sobre la situación laboral y la posible modulación de los resultados por la CVRS evaluada mediante el QLACS. Resultados: Sólo el 55% de los supervivientes de cáncer estaban empleados. La edad, la cualificación y el tipo de cáncer fueron predictores independientes de la situación laboral, así como de la fase de supervivencia en los supervivientes con una CVRS baja. Conclusiones: Un alto porcentaje de supervivientes en edad laboral no vuelve a trabajar tras la experiencia oncológica. Algunas variables sociodemográficas y relacionadas con la enfermedad pueden ayudar a la identificación precoz de la población de riesgo en la que centrar la atención.

show abstract

Section: Methodsmentioning

confidence: 57%

Returning to work in cancer survivors: a multi-center cross-sectional study in Spain

et al. 2023

View full text Add to dashboard Cite

show abstract

“…Our results are in the range of those obtained in these studies (including samples in different intervals of the survival period). Moreover, the comparison between them suggests a certain improvement over time in the QOL of the cancer survivor, which is particularly evident after the first year of post‐treatment (Andreu et al, 2021; Tessier et al, 2012; Van Leeuwen et al, 2018). Thus, the results obtained by Andreu et al (2021) showed the lowest total QOL as well as negative and positive feelings, fatigue, pain, social avoidance, sexual problems and appearance concerns domains in those survivors who were in the re‐entry phase.…”

Section: Discussionmentioning

confidence: 99%

Section: T a B L E 1 Characteristics Of The Participantsmentioning

confidence: 99%

“…Cancer type, primary treatment strategy, hormone therapy, age, gender, employment and marital status were taken into account as modulating variables. In addition, the possible predictive role of other variables analysed in a previous study, such as time since the end of treatment (Andreu et al, 2021) was also considered when discussing results from the present research.…”

Section: Introductionmentioning

confidence: 99%

“…There are a few instruments designed specifically for cancer survivors, as distinct from cancer patients, that address psychosocial concerns relevant to this population: Cancer Problems in Living Scale (CPILS) (Baker et al, 2003), Impact of Cancer (IOC) (Zebrack et al, 2006), Satisfaction with Life Domains Scale for Cancer (SLDS-C) (Baker et al, 2007) and the Quality of Life in Adult Cancer Survivors (QLACS) (Avis et al, 2005). In particular, the psychometric properties of the latter have been more extensively studied (Andreu et al, 2021;Ashley et al, 2014;Avis et al, 2006;Escobar et al, 2015;Sohl et al, 2015).…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Quality of life in cancer survivorship: Sociodemographic and disease‐related moderators

Andreu

Martínez

Soto‐Rubio

et al. 2022

European J Cancer Care

View full text Add to dashboard Cite

Rationale: To identify high-risk survivors in order to provide appropriate care.Purpose: To analyse the quality of life (QOL) of cancer survivors using an instrument designed specifically for this population and considering different sociodemographic and disease-related characteristics as possible modulating variables. Methods:The Quality of Life in Adult Cancer Survivors (QLACS) was filled out by a large and heterogeneous sample of disease-free post-treatment Spanish cancer survivors (N = 1862).Results: QLACS scores were comparable to those obtained in other studies and indicative of worse QOL as a function of shorter elapsed time since the end of primary treatment. The best QOL was shown by prostate, and the worst by hematologic cancer survivors. Both systemic treatments (chemotherapy and hormone therapy) and the combination of radiotherapy and chemotherapy were associated with worse QOL. Likewise, younger age, female sex, unemployment status and not having a stable partner were associated with worse QOL. Conclusion:Greater understanding of the QOL experienced by the already large and continuously growing population of cancer survivors is relevant for guiding both clinical practice and health policy. In addition, knowing the risk factors associated with worse QOL facilitates the development of targeted prevention programmes for those survivors who need it the most.

show abstract

Impact of hormone therapy side effects on health-related quality of life, distress, and well-being of breast cancer survivors

Andreu

Soto‐Rubio

Ramos-Campos

et al. 2022

Sci Rep

View full text Add to dashboard Cite

To explore the modulatory role of Adjuvant Hormone Therapy (AHT) on health-related quality of life (QoL), subjective well-being and distress prevalence in Breast Cancer (BC) survivors, considering the survival phase. Cross-sectional study with control group. 616 BC survivors participated. Examination of interaction effect between AHT and time since end of primary treatment showed that many of the positive changes observed through the survival phases were experienced exclusively by survivors without AHT. When AHT was not prescribed, longer time elapsed was associated with a decrease in distress prevalence and an improvement in subjective well-being and QoL. It seems there is a turning point around the fifth year after finalization of primary treatment, from which the survivors without AHT significantly improve in several areas and those with AHT do so to a lesser extent. It is expected that the improvement in QoL throughout the different survival phases will have a significant impact on the adherence and maintenance of AHT and, consequently, the likelihood of survival. Thus, AHT side-effects should be routinely assessed by health care providers to gain accurate knowledge that allows improving the QoL of BC survivors.

show abstract

Possible substantive improvements in the structure of the Quality of Life in Adult Cancer Survivors (QLACS) scale? A study based on its Spanish version

Cited by 4 publications

References 40 publications

Returning to work in cancer survivors: a multi-center cross-sectional study in Spain

Returning to work in cancer survivors: a multi-center cross-sectional study in Spain

Quality of life in cancer survivorship: Sociodemographic and disease‐related moderators

Impact of hormone therapy side effects on health-related quality of life, distress, and well-being of breast cancer survivors

Contact Info

Product

Resources

About